Clinical TrialsSearch results
Number of results: 68528
Recruiting
- Research on the clinical utility and benefits of whole genome analysis in patients of refractory cancer
- Refractory cancers (including rare cancers, AYA cancers, and cancers of unknown primary origin)
- Yuichi Ando
- 2024-09-26
Recruiting
- Phase 3 Conjunctival Allergen Challenge Trial of NTa53
- Allergic Conjunctivitis
- Hasunuma Tomoko
- 2024-09-26
Recruiting
- Phase 3 a long-term administration study of NTa53
- Allergic Conjunctivitis
- Yonemichi Takeshi
- 2024-09-26
Recruiting
- Multicenter collaborative study on the comprehensive collection and utilization of in-hospital real-world data (RWD) on cancer care.
- Cancer
- Muto Manabu
- 2024-09-26
Not yet recruiting
- Phase II clinical trial of hypofractionated image-guided proton beam therapy for loalized prostate cancer
- Prostate cancer
- SAKURAI HIDEYUKI
- 2024-09-26
Other
- Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation (AGILE)
- Acute Myeloid Leukemia (AML)
- Kamemura Nobuto
- 2024-09-26
Recruiting
- The effects on immune function
- Healthy Japanese
- ORTHOMEDICO Inc.
- 2024-09-25
Recruiting
- Setrusumab in pediatric Japanese subjects with osteogenesis imperfecta
- Osteogenesis Imperfecta
- Stanley J. Krolczyk, MD
- 2024-09-25
Recruiting
- Observational study for conversion rate to surgery in the patients who are planned to be treated with Durvalumab with Gemcitabine plus Cisplatin due to unresectable biliary tract cancers by locally advance or oligo-metastasis (GC-D conversion study) CSGO-HBP024
- to investigate conversion rate to surgery in the patients who are treated with gemcitabine, cisplatin, and durvalumab (GC-D)
- Osaka University
- 2024-09-25
Recruiting
- Investigation of the usefulness of duklavacitinib in early onset psoriasis
- Psoriasis vulgaris
- Morita Akimichi
- 2024-09-25